Hanmi signs deal to transfer entecavir synthesis technology to Hwail

Published: 2010-12-17 06:56:00
Updated: 2010-12-17 06:56:00
Hanmi Pharmaceutical Co. signed Wednesday a license-out agreement with Hwail Pharmaceutical Co., a local pharmaceutical bulk maker, to transfer its new synthesis technology of entecavir.

Hanmi officials said that, under the agreement, Hwail will be able to produce entecavir until 2025 to meet ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.